Cardiovascular outcomes, bleeding risk, and achieved blood pressure in patients on long-term anticoagulation with the thrombin antagonist dabigatran or warfarin: data from the RE-LY trial
Böhm, Michael, Brueckmann, Martina, Eikelboom, John W, Ezekowitz, Michael, FräÃdorf, Mandy, Hijazi, Ziad, Hohnloser, Stefan H, Mahfoud, Felix, Schmieder, Roland E, Schumacher, Helmut, Wallentin, LaJournal:
European Heart Journal
DOI:
10.1093/eurheartj/ehaa247
Date:
May, 2020
File:
PDF, 1.54 MB
2020
File converter
More search results
More benefits 
